Noah Weiss litigates high-stakes civil and criminal matters for both individuals and corporations. In civil cases, Noah has represented clients in a wide range of substantive areas, including commercial disputes, financial services litigation, class actions, False Claims Act cases, telecast rights litigation, and executive compensation disputes. In criminal and investigations matters, Noah has guided corporations, senior executives, and public officials through inquiries conducted by various federal and state entities and agencies, including the U.S. Congress, Department of Justice, and Securities and Exchange Commission. Noah also works closely with in-house counsel to lead internal investigations into compliance and whistleblower allegations. In addition, Noah has significant experience in international economic sanctions matters, including representations of companies and individuals before the U.S. Treasury’s Office of Foreign Assets Control.
While an associate at the firm, Noah was seconded in-house at Medtronic, Inc. working on government and internal investigations.
Born and raised in Los Angeles, California, Noah graduated summa cum laude from the University of Pennsylvania and cum laude from Harvard Law School, where he won the Ames Moot Court Competition and was a member of the Harvard Law Review. Before joining the firm, Noah clerked for the Honorable Thomas M. Hardiman of the U.S. Court of Appeals for the Third Circuit.
- The Supreme Court, 2010 Term - Leading Cases: J. McIntyre Machinery, Ltd. v. Nicastro, 125 Harv. L. Rev. 311 (2011)
- Recent Case: Stewart v. State, 124 Harv. L. Rev. 1596 (2011)
Though all cases vary, and none is predictive, Noah’s experience includes:
- Defending a global financial institution in a series of RMBS-related litigations arising from its role as a securitization trustee
- Representing a major American sports league in litigation concerning telecast rights
- Defended a major international bank in securities litigation, winning the complete dismissal of claims alleging over $500 million in damages
- Defended a publicly traded company accused of overcharging a municipal government. In 2020, on the final business day before a three-week jury trial was scheduled to begin, the plaintiff voluntarily dismissed its case with prejudice with the firm’s client making no payment of any kind
- Represented a global medical device corporation in a contract dispute with the former shareholders of an acquired company
- Represented the former CEO of a Fortune 25 company in a joint DOJ-SEC investigation involving the Foreign Corrupt Practices Act
- Represented a national medical device company in a healthcare fraud investigation
- Represented a Fortune 500 corporation in qui tam false claims litigation in California federal and state courts; after years of litigation, the litigation was resolved by complex settlements